NCIC Clinical Trials Group: Breast Neoplasms trials

The registry lists 20 Breast Neoplasms studies with NCIC Clinical Trials Group as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 4Phase 2 7Phase 3 8No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast CancerCompletedNCT00083174Phase 3Results posted
• Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast CancerCompletedNCT00066573Phase 3Results posted
• Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast CancerCompletedNCT00014222Phase 3Results posted
• Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast CancerCompletedNCT00005957Not applicableResults posted
• A Study of Foretinib in Patients With Recurrent/Metastatic Breast CancerCompletedNCT01147484Phase 2
• Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast CancerCompletedNCT01138384Phase 1/2
• Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3CompletedNCT00688246
• Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryCompletedNCT00482755Phase 2
• OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCompletedNCT00471432Phase 1
• Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical TrialCompletedNCT00354302Phase 3
• OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00258375Phase 2
• Everolimus in Treating Patients WIth Recurrent or Metastatic Breast CancerCompletedNCT00255788Phase 2
• Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast DensityCompletedNCT00238316Phase 2
• Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast CancerCompletedNCT00066586Not applicable
• Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast CancerCompletedNCT00066443Phase 1/2
• Letrozole After Tamoxifen in Treating Women With Breast CancerCompletedNCT00003140Phase 3
• High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast CancerCompletedNCT00003032Phase 3
• Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast CancerCompletedNCT00002866Phase 1
• Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00002864Phase 3
• Tamoxifen in Treating Women With High-Risk Breast CancerCompletedNCT00002542Phase 3